BridgeBio Pharma, Inc.
Total Trades
112
Buys
9
Sells
74
Largest Trade
N/A
Insiders
16
Institutional Funds
358
Inst. Value
$1M+
Activist Filings
26
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Ellis Andrea | Director | SELL | $1M+ | 65K | $64.87 | Mar 6, 2026 |
| Ellis Andrea | Director | EXERCISE | $500K+ | 65K | $8.45 | Mar 6, 2026 |
| Valantine Hannah | Director | SELL | $1M+ | 25K | $67.41 | Mar 3, 2026 |
| Valantine Hannah | Director | EXERCISE | $1M+ | 25K | $48.45 | Mar 3, 2026 |
| Apuli Maricel | Chief Accounting O… | SELL | $100K–$500K | 2K | $66.00 | Feb 27, 2026 |
| Apuli Maricel | Chief Accounting O… | SELL | $15K–$50K | 510 | $74.31 | Feb 18, 2026 |
| Trimarchi Thomas | President and CFO | SELL | $1M+ | 14K | $74.72 | Feb 18, 2026 |
| Scott Randal W. | Director | SELL | $500K+ | 10K | $75.46 | Feb 18, 2026 |
| Scott Randal W. | Director | EXERCISE | $100K–$500K | 10K | $16.75 | Feb 18, 2026 |
| Kumar Neil | CEO | SELL | $1M+ | 80K | $71.86 | Feb 12, 2026 |
| Kumar Neil | CEO | SELL | $1M+ | 80K | $75.54 | Jan 13, 2026 |
| Kumar Neil | CEO | SELL | $1M+ | 30K | $74.64 | Dec 16, 2025 |
| Kumar Neil | CEO | EXERCISE | N/A | 61K | — | Dec 16, 2025 |
| Apuli Maricel | Chief Accounting O… | SELL | $100K–$500K | 2K | $74.26 | Dec 10, 2025 |
| Kumar Neil | CEO | SELL | $1M+ | 80K | $73.86 | Dec 8, 2025 |
| Kumar Neil | CEO | SELL | $1M+ | 26K | $65.84 | Nov 24, 2025 |
| Lo Andrew | Director | SELL | $1M+ | 96K | $66.11 | Nov 19, 2025 |
| Scott Randal W. | Director | EXERCISE | $100K–$500K | 10K | $16.75 | Nov 19, 2025 |
| Scott Randal W. | Director | SELL | $500K+ | 10K | $66.65 | Nov 19, 2025 |
| Trimarchi Thomas | President and CFO | SELL | $1M+ | 17K | $66.46 | Nov 19, 2025 |
| Valantine Hannah | Director | SELL | $1M+ | 25K | $66.07 | Nov 14, 2025 |
| Valantine Hannah | Director | EXERCISE | $1M+ | 25K | $48.45 | Nov 14, 2025 |
| Kumar Neil | CEO | SELL | $1M+ | 80K | $62.29 | Nov 10, 2025 |
| DANIELS RONALD J | Director | EXERCISE | $1M+ | 61K | $34.65 | Nov 7, 2025 |
| DANIELS RONALD J | Director | SELL | $1M+ | 61K | $63.72 | Nov 7, 2025 |
| MCCORMICK FRANK | Director | SELL | $1M+ | 198K | $66.58 | Oct 31, 2025 |
| MCCORMICK FRANK | Director | SELL | $100K–$500K | 2K | $65.00 | Oct 29, 2025 |
| MCCORMICK FRANK | Director | SELL | $1M+ | 74K | $53.16 | Sep 8, 2025 |
| MCCORMICK FRANK | Director | EXERCISE | $500K+ | 74K | $11.92 | Sep 8, 2025 |
| Kumar Neil | CEO | SELL | $1M+ | 80K | $52.20 | Sep 8, 2025 |
| Trimarchi Thomas | President and CFO | SELL | $1M+ | 42K | $49.48 | Aug 22, 2025 |
| Kumar Neil | CEO | SELL | $1M+ | 26K | $48.82 | Aug 22, 2025 |
| Kumar Neil | CEO | SELL | $1M+ | 80K | $42.63 | Jul 3, 2025 |
| VIKING GLOBAL INVESTORS LP | 10% Owner | SELL | $1M+ | 3.5M | $44.00 | Jul 1, 2025 |
| Valantine Hannah | Director | SELL | $100K–$500K | 5K | $44.05 | Jun 30, 2025 |
| MCCORMICK FRANK | Director | SELL | $1M+ | 100K | $44.23 | Jun 26, 2025 |
| Valantine Hannah | Director | EXERCISE | $50K–$100K | 4K | $16.75 | Jun 11, 2025 |
| Valantine Hannah | Director | SELL | $100K–$500K | 4K | $40.00 | Jun 11, 2025 |
| Kumar Neil | CEO | SELL | $1M+ | 101K | $33.38 | May 20, 2025 |
| Kumar Neil | CEO | EXERCISE | N/A | 65K | — | May 20, 2025 |
| KKR Genetic Disorder L.P. | 10% Owner | SELL | $1M+ | 6.0M | $34.20 | May 14, 2025 |
| Apuli Maricel | Chief Accounting O… | SELL | $15K–$50K | 1K | $38.51 | May 6, 2025 |
| Lo Andrew | Director | SELL | $1M+ | 100K | $38.50 | May 6, 2025 |
| Kumar Neil | CEO | SELL | $1M+ | 75K | $34.11 | Apr 24, 2025 |
| Ellis Andrea | Director | EXERCISE | $50K–$100K | 10K | $8.45 | Apr 16, 2025 |
| Ellis Andrea | Director | SELL | $100K–$500K | 10K | $35.00 | Apr 16, 2025 |
| Ellis Andrea | Director | EXERCISE | $100K–$500K | 30K | $8.45 | Apr 3, 2025 |
| Ellis Andrea | Director | SELL | $1M+ | 30K | $34.05 | Apr 3, 2025 |
| Kumar Neil | CEO | SELL | $1M+ | 75K | $36.87 | Mar 27, 2025 |
| STEPHENSON BRIAN C | CFO and Treasurer | SELL | $100K–$500K | 9K | $33.19 | Feb 27, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 358 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 14.4M | $1M+ | SH |
| Aisling Capital Management LP | 5.1M | $1M+ | SH |
| STATE STREET CORP | 5.0M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 3.9M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 3.5M | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 2.1M | $1M+ | SH |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2.0M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.0M | $1M+ | SH |
| Capital Research Global Investors | 1.9M | $1M+ | SH |
| SC US (TTGP), LTD. | 1.9M | $1M+ | SH |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.7M | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 1.6M | $1M+ | SH |
| NORGES BANK | 1.5M | $1M+ | SH |
| Laurion Capital Management LP | 1.4M | $1M+ | SH |
| Pictet Asset Management Holding SA | 1.3M | $1M+ | SH |
| Ensign Peak Advisors, Inc | 1.3M | $1M+ | SH |
| Cormorant Asset Management, LP | 1.2M | $1M+ | SH |
| VANGUARD GROUP INC | 1.2M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 1.1M | $1M+ | SH |
| Deep Track Capital, LP | 810K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Feb 18, 2026
6.8%
13.0M shares
SC 13G · Feb 17, 2026
5.7%
11.0M shares
SC 13D/A · Nov 14, 2025
8.2%
15.9M shares
SC 13D/A · Aug 15, 2025
9.3%
17.8M shares
SC 13G/A · Jul 29, 2025
8.7%
16.5M shares
SC 13D/A · Jul 1, 2025
9.8%
18.6M shares
SC 13D/A · May 14, 2025
7.0%
13.3M shares
SC 13D/A · Mar 12, 2025
11.7%
22.1M shares
SC 13D/A · Mar 7, 2025
10.1%
19.3M shares
SC 13G/A · Feb 13, 2025
5.4%
10.5M shares
SC 13D/A · Feb 1, 2025
11.7%
22.1M shares
SC 13G/A · Nov 12, 2024
6.8%
12.9M shares
SC 13D/A · Nov 6, 2024
13.4%
25.1M shares
SC 13G/A · Oct 22, 2024
6.8%
12.9M shares
SC 13D/A · Sep 17, 2024
13.4%
25.3M shares
SC 13D/A · Aug 21, 2024
13.4%
25.1M shares
SC 13G/A · Feb 17, 2024
5.6%
10.0M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
7.4%
12.8M shares
SC 13G/A · Jan 29, 2024
5.8%
10.2M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 23, 2024
2.9%
0 shares
SC 13D/A · Nov 22, 2023
15.7%
25.1M shares
SC 13D/A · Jul 20, 2023
15.7%
25.1M shares
S.S. OR I.R.S IDENTIFICATION NOS. OF ABOVE PERSONS NEIL KUMAR
SC 13G/A · Feb 14, 2023
6.4%
9.8M shares
SC 13G/A · Jan 31, 2023
6.6%
9.8M shares
SC 13G/A · Feb 15, 2022
4.8%
7.1M shares
S.S. OR I.R.S IDENTIFICATION NOS. OF ABOVE PERSONS NEIL KUMAR
SC 13G/A · Feb 14, 2022
6.0%
9.0M shares